StockPriceToday
Roper Technologies Inc (ROP)
About Roper Technologies Inc
Roper Technologies Inc. operates as a diversified technology company that provides software and engineered products serving healthcare, transportation, energy, and other specialized markets. The company's focus on niche software markets has made ROP stock price relatively stable with growth driven by strategic acquisitions and organic expansion.
Roper's software businesses provide mission-critical solutions for hospitals, laboratories, government agencies, and various other specialized markets. The company's solutions often have high switching costs and generate recurring revenue through licenses, maintenance, and transaction fees.
The company's engineered products include industrial controls, fluid handling systems, and testing equipment that serve specialized applications across multiple industries. Roper's acquisition strategy focuses on profitable software businesses with strong market positions, positively influencing ROP stock price trends.
Roper's disciplined approach to capital allocation and focus on cash flow generation have created consistent shareholder returns through dividends and share repurchases. The company's ability to identify and integrate strategic acquisitions while maintaining operational excellence remains crucial for its continued growth and market valuation.
ROP Stock 12 Month Chart
Latest News for ROP
Oakmark Funds, advised by Harris Associates, released its “Oakmark Fund” first-quarter 2026 investor letter. The objective of the fund is to deliver capital appreciation by investing in diverse ...
Quite a few insiders have dramatically grown their holdings in Roper Technologies, Inc. ( NASDAQ:ROP ) over the past ...
Roper Technologies, Inc. ROP is benefiting from strong momentum in its Application Software segment, driven by strength across its Aderant, Deltek, Vertafore and PowerPlan businesses. It is ...
Other Popular Stocks
4D Molecular Therapeutics Inc. (FDMT) is a clinical-stage biotechnology company developing gene therapy products using novel adeno-associated virus vectors for treating genetic diseases.
Spero Therapeutics Inc. (SPRO) is a clinical-stage biopharmaceutical company developing novel therapies to treat multi-drug resistant bacterial infections and rare diseases through innovative drug...
Pinnacle Financial Partners Inc. (PNFP) is a bank holding company operating primarily in Tennessee, North Carolina, South Carolina, and Virginia, providing a full range...